Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms

BACKGROUND: Infections caused by multiply drug resistant organisms such as extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae are increasing. Carbapenems (imipenem and meropenem) are the antibiotics commonly used to treat these agents. There is limited clini...

詳細記述

保存先:
書誌詳細
主要な著者: Mody, Rupal M, Erwin, Daniel P, Summers, Amy M, Carrero, Hector A, Selby, Edward B, Ewell, Allesa J, Moran, Kimberly A
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2007
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1894638/
https://ncbi.nlm.nih.gov/pubmed/17553151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-0711-6-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料